Kolkata, India

Pradyot Bhattacharya

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2016.



Average Co-Inventor Count = 21.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pradyot Bhattacharya: Innovator in Bronchial Asthma Treatment

Introduction

Pradyot Bhattacharya is a notable inventor based in Kolkata, India. He has made significant contributions to the field of medical science, particularly in the treatment of bronchial asthma. His innovative approach focuses on the inhibition of specific pathways that contribute to this respiratory condition.

Latest Patents

Pradyot Bhattacharya holds a patent for "Substituted catechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma." This invention relates to compounds of general formula 1 that target the IL-4 and IL-5 pathways to treat bronchial asthma. The patent outlines methods for administering these compounds through various routes, including oral, intranasal, or inhalation, to effectively reduce perivascular and peribronchial inflammation.

Career Highlights

Pradyot is associated with the Council of Scientific and Industrial Research, where he has been involved in groundbreaking research. His work has the potential to improve the quality of life for individuals suffering from asthma by providing new therapeutic options.

Collaborations

He has collaborated with notable colleagues such as Santu Bandyopadhyay and Balaram Ghosh, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Pradyot Bhattacharya's contributions to the field of asthma treatment through his patented inventions highlight his role as a key innovator in medical research. His work continues to pave the way for advancements in therapeutic strategies for respiratory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…